APA (7th ed.) Citation

M, M., KG, J., BJ, S., RS, T., JD, D., DM, M., . . . JB, B. (2023). A blood biomarker test for brain amyloid impacts the clinical evaluation of cognitive impairment. Annals of clinical and translational neurology, 10(10), 1738. https://doi.org/10.1002/acn3.51863

Chicago Style (17th ed.) Citation

M, Monane, et al. "A Blood Biomarker Test for Brain Amyloid Impacts the Clinical Evaluation of Cognitive Impairment." Annals of Clinical and Translational Neurology 10, no. 10 (2023): 1738. https://doi.org/10.1002/acn3.51863.

MLA (9th ed.) Citation

M, Monane, et al. "A Blood Biomarker Test for Brain Amyloid Impacts the Clinical Evaluation of Cognitive Impairment." Annals of Clinical and Translational Neurology, vol. 10, no. 10, 2023, p. 1738, https://doi.org/10.1002/acn3.51863.